Form 4 Filing for Nancy McKinstry

This filing details transactions made by Nancy McKinstry, a director at Abbott Laboratories. On April 24, 2026, McKinstry was granted 2,286 restricted stock units under the Abbott Laboratories 2026 Incentive Stock Program. These units are payable in Abbott common shares upon separation from service, death, or a change in control. Additionally, McKinstry was granted an option to buy 2,305 common shares with an exercise price of $91.86, also under the 2026 Incentive Stock Program. This option is exempt from Section 16 reporting requirements under Rule 16b-3. Following these transactions, McKinstry holds 41,010 shares of common stock and 2,305 options.